This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Brain-computer interface (BCI) technology developer Cognixion, and eye-tracking ...
Innovative cardiac devices are changing how we treat heart defects, offering les...
Guardant Health's Shield multi-cancer detection (MCD) test has secured the US Fo...
The French National Agency for the Safety of Medicines and Health Products (ANSM...
Reports have emerged that the European Union (EU) has voted to ban Chinese compa...
Johnson & Johnson MedTech has introduced the KINCISE 2 Surgical Automated System...
Zest has unveiled a new app-based cognitive test designed to screen for the earl...
Finland’s University of Turku researchers have developed a fluorescent probe for...
Brain-computer interface (BCI) technologies are advancing rapidly, and – as with...
With early detection of prostate cancer recognised as a critical part in reducin...
GE HealthCare and PT Kalbe Farma Tbk (Kalbe) have launched the first computed to...
Neuralink has secured $650m in a Series E financing round, marking a milestone i...
Vantive is investing $1bn towards advancing its kidney care and vital organ supp...
Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation ...
A new EU consortium has launched with the aim to reduce pancreatic cancer mortal...
Harbinger Health has reported clinical data at the American Society of Clinical ...
The US Food and Drug Administration (FDA) has granted breakthrough device design...
The UK National Health Service (NHS) England has rolled out a new liquid biopsy ...
Danaher Corporation has announced a collaboration with AstraZeneca for diagnosti...
Spring steel is undergoing a transformation as high-performance engineering dema...
New research has shown that the ArteraAI test can help identify which men with n...
Acclaro Medical has completed a Series B funding round, raising $23m, to spur th...
Moximed has announced the treatment of the first subject in the MOTION randomise...
HistoSonics' Edison histotripsy system has been granted controlled early limited...